| View |
DR-XY41692_PI_01.pdf
|
DR-XY41692
|
Glucose/ Amino Acids/ Electrolytes/ Vitamin B1
|
Bfluid
|
|
Solution For Peripheral Venous Infusion
|
-
|
PT. Otsuka Indonesia
|
Indonesia
|
-
|
20 December 2019
|
20 December 2024
|
| View |
DR-XY41696_PI_01.pdf
|
DR-XY41696
|
Abiraterone Acetate
|
Zytiga
|
250 mg
|
Tablet
|
-
|
Patheon Inc.
|
Canada
|
Initial (from Monitored Release Extension)
|
30 May 2022
|
15 February 2026
|
| View |
|
DR-XY41709
|
Iohexol
|
Iobrix 350
|
755 mg/mL (equivalent to the 350mg of Iodine)
|
Solution For Injecion (I.V)
|
Radiocontrast Medium
|
Taejoon Pharm. Co., Ltd.
|
Korea
|
Automatic Renewal
|
13 December 2022
|
21 February 2028
|
| View |
|
DR-XY4171
|
Paracetamol
|
Cristicol
|
125mg/5mL
|
Syrup
|
Analgesic / Antipyretic
|
Pharmatechnica Laboratory, Inc.
|
Philippines
|
Automatic Renewal
|
13 June 2023
|
04 May 2028
|
| View |
|
DR-XY41716
|
Carboplatin
|
Biovinate
|
10 mg/mL (450 mg/ 45 mL)
|
Solution For Iv Infusion
|
Antineoplastic Agent (Platinum Compound)
|
Beacon Pharmaceuticals Limited
|
Bangladesh
|
Renewal
|
22 March 2023
|
21 February 2028
|
| View |
|
DR-XY41717
|
Carboplatin
|
Biovinate
|
10 mg/ mL (150 mg/ 15 mL)
|
Solution For Iv Infusion
|
Antineoplastic Agent (Platinum Compound)
|
Beacon Pharmaceuticals Limited
|
Bangladesh
|
Renewal
|
22 March 2023
|
21 February 2028
|
| View |
|
DR-XY41718
|
Water For Injection
|
None
|
None
|
Solution for Injection (IV)
|
Rehydration Solution (Parenteral)
|
CSPC Ouyi Pharmaceutical Co., Ltd.
|
China
|
Initial (Variation)
|
30 August 2022
|
30 August 2027
|
| View |
|
DR-XY41721
|
Clarithromycin
|
Myzin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
19 February 2023
|
21 February 2028
|
| View |
|
DR-XY41725
|
Amphotericin B
|
Amfucin
|
50 mg
|
Lyophilized Powder for Injection (IV)
|
-
|
U Square Lifesciences Pvt. Ltd.
|
India
|
-
|
28 September 2020
|
17 June 2025
|
| View |
|
DR-XY41726
|
Ambroxol Hydrochloride
|
Mucosolvan 24Hrs
|
75 mg
|
Sustained Release Capsule
|
Mucolytic
|
Boehringer Ingelheim Pharma GmbH & Co. KG
|
Germany
|
Automatic Renewal
|
20 January 2023
|
28 February 2028
|
| View |
|
DR-XY41729
|
Clarithromycin
|
Macromycin
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
07 March 2023
|
28 February 2028
|
| View |
|
DR-XY41743
|
L-Ornithine-L-Aspartate
|
Hepa-Merz
|
5g/10mL
|
Concentrate Solution For I.V. Infusion
|
Hepatic Protectant
|
B. Braun Melsungen Ag
|
Germany
|
Automatic Renewal
|
31 December 2022
|
22 February 2028
|
| View |
|
DR-XY41745
|
Calcipotriol (as Monohydrate) + Betamethasone (as dipropionate)
|
DAIVOBET
|
50 mcg/500 mcg per gram
|
Topical Gel
|
Anti-psoriais
|
Leo Laboratories Ltd.
|
Ireland
|
Renewal
|
27 October 2024
|
21 January 2030
|
| View |
|
DR-XY41746
|
Sodium Chloride
|
Breathe Ezy
|
0.0065
|
Buffered Solution Nasal Spray
|
Nasal Decongestant
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
12 January 2022
|
25 February 2028
|
| View |
|
DR-XY41747
|
Clopidogrel
|
Clopate
|
75 mg
|
Film Coated tablet
|
Antithrombotic / Antiplatelet
|
Unicure Remedies Pvt. Ltd.
|
India
|
Automatic Renewal
|
03 January 2023
|
25 February 2028
|
| View |
|
DR-XY41749
|
Sodium Chloride
|
Breathe Ezy
|
0.0065
|
Buffered Solution Nasal Drops
|
Irrigating Solution
|
Lloyd Laboratores, Inc.
|
Philippines
|
Automatic Renewal
|
07 December 2022
|
25 February 2028
|
| View |
|
DR-XY41756
|
Salbutamol (as sulfate)
|
Ventolax
|
200 mcg
|
Dry powder for Inhalation
|
Bronchodilator
|
Jewim Pharmaceutical (Shandong) Co., Ltd.
|
China
|
Renewal
|
22 March 2023
|
01 April 2028
|
| View |
|
DR-XY41760
|
Ibuprofen
|
Medicol Advance 400
|
400 mg
|
Softgel Capsule
|
-
|
Belmont Softgel Pharma Corporation
|
Philippines
|
Initial (Variation)
|
21 July 2022
|
06 June 2027
|
| View |
|
DR-XY41764
|
Multivitamins +Minerals
|
Rejuvon Ob Forte
|
|
Capsule
|
Vitamins/Minerals
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
10 March 2023
|
08 March 2028
|
| View |
|
DR-XY41771
|
Paclitaxel
|
Intaxel
|
6mg/mL
|
Concentrate Sterile Solution For Iv Infusion
|
Antineoplastic (Cell Cycle-Specific Agent)
|
Fresenius Kabi Oncology Ltd.
|
India
|
Automatic Renewal
|
18 January 2023
|
07 March 2028
|